Peters MF - Search Results

1

Developing in vitro assays to transform gastrointestinal safety assessment: potential for microphysiological systems.

Peters MF, Choy AL, Pin C, Leishman DJ, Moisan A, Ewart L, Guzzie-Peck PJ, Sura R, Keller DA, Scott CW, Kolaja KL. Peters MF, et al. Lab Chip. 2020 Apr 7;20(7):1177-1190. doi: 10.1039/c9lc01107b. Epub 2020 Mar 4. Lab Chip. 2020. PMID: 32129356 Review.

2

Evaluating cellular impedance assays for detection of GPCR pleiotropic signaling and functional selectivity.

Peters MF, Scott CW. Peters MF, et al. J Biomol Screen. 2009 Mar;14(3):246-55. doi: 10.1177/1087057108330115. Epub 2009 Feb 11. J Biomol Screen. 2009. PMID: 19211780

3

Human stem cell-derived cardiomyocytes in cellular impedance assays: bringing cardiotoxicity screening to the front line.

Peters MF, Lamore SD, Guo L, Scott CW, Kolaja KL. Peters MF, et al. Cardiovasc Toxicol. 2015 Apr;15(2):127-39. doi: 10.1007/s12012-014-9268-9. Cardiovasc Toxicol. 2015. PMID: 25134468 Review.

4

Human 3D Gastrointestinal Microtissue Barrier Function As a Predictor of Drug-Induced Diarrhea.

Peters MF, Landry T, Pin C, Maratea K, Dick C, Wagoner MP, Choy AL, Barthlow H, Snow D, Stevens Z, Armento A, Scott CW, Ayehunie S. Peters MF, et al. Toxicol Sci. 2019 Mar 1;168(1):3-17. doi: 10.1093/toxsci/kfy268. Toxicol Sci. 2019. PMID: 30364994 Free PMC article.

5

Human ileal organoid model recapitulates clinical incidence of diarrhea associated with small molecule drugs.

Belair DG, Visconti RJ, Hong M, Marella M, Peters MF, Scott CW, Kolaja KL. Belair DG, et al. Among authors: peters mf. Toxicol In Vitro. 2020 Oct;68:104928. doi: 10.1016/j.tiv.2020.104928. Epub 2020 Jul 3. Toxicol In Vitro. 2020. PMID: 32622998 Free article.

6

Label-free whole-cell assays: expanding the scope of GPCR screening.

Scott CW, Peters MF. Scott CW, et al. Among authors: peters mf. Drug Discov Today. 2010 Sep;15(17-18):704-16. doi: 10.1016/j.drudis.2010.06.008. Epub 2010 Jun 23. Drug Discov Today. 2010. PMID: 20601093 Review.

7

Evaluation of cellular impedance measures of cardiomyocyte cultures for drug screening applications.

Peters MF, Scott CW, Ochalski R, Dragan YP. Peters MF, et al. Assay Drug Dev Technol. 2012 Dec;10(6):525-32. doi: 10.1089/adt.2011.442. Epub 2012 May 10. Assay Drug Dev Technol. 2012. PMID: 22574652

8

Human induced pluripotent stem cells and their use in drug discovery for toxicity testing.

Scott CW, Peters MF, Dragan YP. Scott CW, et al. Among authors: peters mf. Toxicol Lett. 2013 May 10;219(1):49-58. doi: 10.1016/j.toxlet.2013.02.020. Epub 2013 Mar 5. Toxicol Lett. 2013. PMID: 23470867 Review.

9

Cardiovascular Toxicity Induced by Kinase Inhibitors: Mechanisms and Preclinical Approaches.

Lamore SD, Kohnken RA, Peters MF, Kolaja KL. Lamore SD, et al. Among authors: peters mf. Chem Res Toxicol. 2020 Jan 21;33(1):125-136. doi: 10.1021/acs.chemrestox.9b00387. Epub 2020 Jan 10. Chem Res Toxicol. 2020. PMID: 31840498 Review.

10

Comparing label-free biosensors for pharmacological screening with cell-based functional assays.

Peters MF, Vaillancourt F, Heroux M, Valiquette M, Scott CW. Peters MF, et al. Assay Drug Dev Technol. 2010 Apr;8(2):219-27. doi: 10.1089/adt.2009.0232. Assay Drug Dev Technol. 2010. PMID: 20085460

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters